Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

NNASDAQ:ELVN
46.85
USD
-0.77
(-1.62%)
-1.69EPS
3.37BMarket Cap
Mar 18Next Earn

Enliven Therapeutics, Inc. Documents

Q2 FY2024 · Quarterly report

August 13, 2024 · 115 pages

Read Enliven Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q2 FY2024 documents